Vascular Age: A narrative review of assessment methods, clinical applications, and future directions

Cardiovascular disease (CVD) is the leading cause of death and disability globally, highlighting the importance of effective risk assessment and early intervention. However, traditional risk assessment models based on common risk factors have limitations, particularly for stratifying intermediate-risk individuals. Vascular age (VA), a biological marker combining multiple cardiovascular risk factors and cumulative damage to the vascular system, has gained increasing attention as a more intuitive understanding of vascular health than chronological age. This may facilitate clearer physician-patient communication, and promote lifestyle changes and treatment adherence. This review summarizes methods for assessing VA and recent clinical advances. It explains popular evaluation techniques, including those based on arterial stiffness (such as pulse wave velocity), vascular structure (e.g., carotid intima-media thickness, coronary artery calcium score), vascular function, and multifactorial risk-scoring models. Emerging technologies using artificial intelligence (e.g., deep learning) to estimate VA from photoplethysmography or retinal images are also discussed. The review highlights the role of VA in improving CVD risk stratification, improving patient communication and adherence, guiding personalized treatments, and its application to specific populations (including those with diabetes and rheumatoid arthritis). It emphasizes key concepts such as early vascular aging and supernormal vascular aging. Finally, current challenges are discussed, including the need for standardized assessment methods, establishment of reference values, and evaluation of cost-effectiveness. Future directions such as technological innovations, clinical trial designs, and practical applications are explored. By thoroughly analyzing existing evidence, this review provides a valuable reference for further research and clinical implementation of vascular age.

Authors

Institutions

Publication Details

Journal
International Journal of Cardiology Cardiovascular Risk and Prevention
Published
2026-02-17
DOI
https://doi.org/10.1016/j.ijcrp.2026.200601
Primary Topic
Cardiovascular Health and Disease Prevention
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vascular Age: A narrative review of assessment methods, clinical applications, and future directions

Xiaobo Wang, Lihua Li, Zisu Yang
International Journal of Cardiology Cardiovascular Risk and Prevention
Cardiovascular Health and Disease Prevention
article

Vascular Age: A narrative review of assessment methods, clinical applications, and future directions

Xiaobo Wang, Lihua Li, Zisu Yang
article en

Abstract

Cardiovascular disease (CVD) is the leading cause of death and disability globally, highlighting the importance of effective risk assessment and early intervention. However, traditional risk assessment models based on common risk factors have limitations, particularly for stratifying intermediate-risk individuals. Vascular age (VA), a biological marker combining multiple cardiovascular risk factors and cumulative damage to the vascular system, has gained increasing attention as a more intuitive understanding of vascular health than chronological age. This may facilitate clearer physician-patient communication, and promote lifestyle changes and treatment adherence. This review summarizes methods for assessing VA and recent clinical advances. It explains popular evaluation techniques, including those based on arterial stiffness (such as pulse wave velocity), vascular structure (e.g., carotid intima-media thickness, coronary artery calcium score), vascular function, and multifactorial risk-scoring models. Emerging technologies using artificial intelligence (e.g., deep learning) to estimate VA from photoplethysmography or retinal images are also discussed. The review highlights the role of VA in improving CVD risk stratification, improving patient communication and adherence, guiding personalized treatments, and its application to specific populations (including those with diabetes and rheumatoid arthritis). It emphasizes key concepts such as early vascular aging and supernormal vascular aging. Finally, current challenges are discussed, including the need for standardized assessment methods, establishment of reference values, and evaluation of cost-effectiveness. Future directions such as technological innovations, clinical trial designs, and practical applications are explored. By thoroughly analyzing existing evidence, this review provides a valuable reference for further research and clinical implementation of vascular age.

International Journal of Cardiology Cardiovascular Risk and PreventionVol. 29
Dali University (CN)
Openalex Percentile: Top 57%
Cardiovascular Health and Disease Prevention
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.